A randomized trial of ibrutinib and R‐GDP prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma.

MLA

Kuruvilla, John, et al. “A Randomized Trial of Ibrutinib and R‐GDP Prior to Stem Cell Transplant in Relapsed Diffuse Large B‐cell Lymphoma.” British Journal of Haematology, vol. 205, no. 5, Nov. 2024, pp. 2067–71. EBSCOhost, https://doi.org/10.1111/bjh.19764.

APA

Kuruvilla, J., Rushton, C., Villa, D., Aslam, M., Prica, A., Abdel, S. N., Doucet, S., Dudebout, J., Fleury, I., Fraser, G., Larouche, J., Shafey, M., Skrabek, P., Skamene, T., Morin, R. D., Alcaide, M., Ben, N. S., Lee, D., Winch, C., & Shepherd, L. E. (2024). A randomized trial of ibrutinib and R‐GDP prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma. British Journal of Haematology, 205(5), 2067–2071. https://doi.org/10.1111/bjh.19764

Chicago

Kuruvilla, John, Christopher Rushton, Diego Villa, Muhammad Aslam, Anca Prica, Samad, Nizar Abdel, Stephane Doucet, et al. 2024. “A Randomized Trial of Ibrutinib and R‐GDP Prior to Stem Cell Transplant in Relapsed Diffuse Large B‐cell Lymphoma.” British Journal of Haematology 205 (5): 2067–71. doi:10.1111/bjh.19764.